nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—CACNA1S—pes—muscle cancer	0.0912	0.197	CbGeAlD
Dronedarone—ABCB1—Dactinomycin—muscle cancer	0.0533	0.202	CbGbCtD
Dronedarone—ALB—Methotrexate—muscle cancer	0.038	0.144	CbGbCtD
Dronedarone—ABCB1—Vincristine—muscle cancer	0.0328	0.124	CbGbCtD
Dronedarone—ABCB1—Etoposide—muscle cancer	0.0301	0.114	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—muscle cancer	0.0205	0.0777	CbGbCtD
Dronedarone—ABCB1—Methotrexate—muscle cancer	0.0199	0.0753	CbGbCtD
Dronedarone—CYP3A4—Vincristine—muscle cancer	0.0197	0.0745	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—muscle cancer	0.0193	0.0732	CbGbCtD
Dronedarone—HCN4—cardiac atrium—muscle cancer	0.0188	0.0406	CbGeAlD
Dronedarone—HCN1—head—muscle cancer	0.0185	0.04	CbGeAlD
Dronedarone—CYP3A4—Etoposide—muscle cancer	0.018	0.0683	CbGbCtD
Dronedarone—HCN2—cardiac atrium—muscle cancer	0.0142	0.0307	CbGeAlD
Dronedarone—HCN4—head—muscle cancer	0.014	0.0303	CbGeAlD
Dronedarone—HCN4—testis—muscle cancer	0.0135	0.0293	CbGeAlD
Dronedarone—HCN3—tendon—muscle cancer	0.0132	0.0286	CbGeAlD
Dronedarone—CYP3A4—Doxorubicin—muscle cancer	0.0123	0.0466	CbGbCtD
Dronedarone—HCN3—vagina—muscle cancer	0.0123	0.0265	CbGeAlD
Dronedarone—HCN3—head—muscle cancer	0.0113	0.0245	CbGeAlD
Dronedarone—HCN3—testis—muscle cancer	0.011	0.0237	CbGeAlD
Dronedarone—HCN2—head—muscle cancer	0.0106	0.023	CbGeAlD
Dronedarone—CACNA1F—head—muscle cancer	0.0106	0.023	CbGeAlD
Dronedarone—HCN2—testis—muscle cancer	0.0103	0.0222	CbGeAlD
Dronedarone—CACNB4—tendon—muscle cancer	0.00816	0.0176	CbGeAlD
Dronedarone—Pulmonary toxicity—Methotrexate—muscle cancer	0.00784	0.0572	CcSEcCtD
Dronedarone—CACNB4—vagina—muscle cancer	0.00757	0.0163	CbGeAlD
Dronedarone—KCNK2—tendon—muscle cancer	0.00723	0.0156	CbGeAlD
Dronedarone—CACNB4—head—muscle cancer	0.00699	0.0151	CbGeAlD
Dronedarone—CACNA1S—tendon—muscle cancer	0.00698	0.0151	CbGeAlD
Dronedarone—Pulmonary fibrosis—Etoposide—muscle cancer	0.00676	0.0493	CcSEcCtD
Dronedarone—CACNB4—testis—muscle cancer	0.00675	0.0146	CbGeAlD
Dronedarone—KCNK2—vagina—muscle cancer	0.00671	0.0145	CbGeAlD
Dronedarone—CACNB1—tendon—muscle cancer	0.00651	0.0141	CbGeAlD
Dronedarone—CACNB3—tendon—muscle cancer	0.00625	0.0135	CbGeAlD
Dronedarone—KCNK2—testis—muscle cancer	0.00599	0.0129	CbGeAlD
Dronedarone—CACNB3—vagina—muscle cancer	0.0058	0.0125	CbGeAlD
Dronedarone—CACNB1—head—muscle cancer	0.00558	0.0121	CbGeAlD
Dronedarone—CACNB1—testis—muscle cancer	0.00539	0.0117	CbGeAlD
Dronedarone—CACNB3—head—muscle cancer	0.00535	0.0116	CbGeAlD
Dronedarone—CACNB3—testis—muscle cancer	0.00517	0.0112	CbGeAlD
Dronedarone—CACNB2—cardiac atrium—muscle cancer	0.00482	0.0104	CbGeAlD
Dronedarone—ADRA1B—renal system—muscle cancer	0.00476	0.0103	CbGeAlD
Dronedarone—CACNA1C—smooth muscle tissue—muscle cancer	0.00451	0.00974	CbGeAlD
Dronedarone—CACNA1D—cardiac atrium—muscle cancer	0.00421	0.00909	CbGeAlD
Dronedarone—Interstitial lung disease—Etoposide—muscle cancer	0.0042	0.0306	CcSEcCtD
Dronedarone—CACNB2—tendon—muscle cancer	0.0042	0.00907	CbGeAlD
Dronedarone—Pulmonary fibrosis—Methotrexate—muscle cancer	0.00405	0.0295	CcSEcCtD
Dronedarone—CACNB2—vagina—muscle cancer	0.00389	0.00841	CbGeAlD
Dronedarone—CACNA1C—cardiac atrium—muscle cancer	0.00389	0.00839	CbGeAlD
Dronedarone—Leukocytoclastic vasculitis—Methotrexate—muscle cancer	0.00363	0.0265	CcSEcCtD
Dronedarone—CACNB2—head—muscle cancer	0.0036	0.00777	CbGeAlD
Dronedarone—SCN1A—head—muscle cancer	0.0035	0.00755	CbGeAlD
Dronedarone—CACNB2—testis—muscle cancer	0.00348	0.00751	CbGeAlD
Dronedarone—ADRA1B—head—muscle cancer	0.00319	0.00689	CbGeAlD
Dronedarone—CACNA1D—head—muscle cancer	0.00314	0.00679	CbGeAlD
Dronedarone—CACNA1C—vagina—muscle cancer	0.00314	0.00679	CbGeAlD
Dronedarone—ADRA1D—head—muscle cancer	0.00312	0.00674	CbGeAlD
Dronedarone—CACNA1D—testis—muscle cancer	0.00304	0.00656	CbGeAlD
Dronedarone—ADRB1—cardiac atrium—muscle cancer	0.00303	0.00655	CbGeAlD
Dronedarone—CACNA1C—head—muscle cancer	0.0029	0.00627	CbGeAlD
Dronedarone—CACNA1C—testis—muscle cancer	0.0028	0.00606	CbGeAlD
Dronedarone—ADRA1A—renal system—muscle cancer	0.00268	0.00578	CbGeAlD
Dronedarone—KCNH2—renal system—muscle cancer	0.00259	0.00558	CbGeAlD
Dronedarone—ADRA2C—renal system—muscle cancer	0.00255	0.00551	CbGeAlD
Dronedarone—Interstitial lung disease—Methotrexate—muscle cancer	0.00251	0.0183	CcSEcCtD
Dronedarone—Hypomagnesaemia—Doxorubicin—muscle cancer	0.00243	0.0177	CcSEcCtD
Dronedarone—Cardiac failure congestive—Etoposide—muscle cancer	0.00238	0.0174	CcSEcCtD
Dronedarone—KCNH2—cardiac atrium—muscle cancer	0.00232	0.005	CbGeAlD
Dronedarone—Pneumonia—Dactinomycin—muscle cancer	0.00231	0.0169	CcSEcCtD
Dronedarone—ADRA2C—cardiac atrium—muscle cancer	0.00228	0.00493	CbGeAlD
Dronedarone—ADRB1—head—muscle cancer	0.00226	0.00489	CbGeAlD
Dronedarone—Cardiac failure—Etoposide—muscle cancer	0.00221	0.0161	CcSEcCtD
Dronedarone—ALB—testis—muscle cancer	0.00218	0.0047	CbGeAlD
Dronedarone—Photosensitivity reaction—Vincristine—muscle cancer	0.0021	0.0153	CcSEcCtD
Dronedarone—Dermatitis atopic—Doxorubicin—muscle cancer	0.00208	0.0152	CcSEcCtD
Dronedarone—Pneumonia—Vincristine—muscle cancer	0.00206	0.0151	CcSEcCtD
Dronedarone—Rash erythematous—Doxorubicin—muscle cancer	0.00201	0.0147	CcSEcCtD
Dronedarone—ADRA2C—tendon—muscle cancer	0.00199	0.0043	CbGeAlD
Dronedarone—KCNH2—bone marrow—muscle cancer	0.00195	0.00422	CbGeAlD
Dronedarone—Ageusia—Doxorubicin—muscle cancer	0.0019	0.0139	CcSEcCtD
Dronedarone—KCNH2—vagina—muscle cancer	0.00187	0.00404	CbGeAlD
Dronedarone—ADRA2C—vagina—muscle cancer	0.00185	0.00399	CbGeAlD
Dronedarone—Liver injury—Doxorubicin—muscle cancer	0.00183	0.0134	CcSEcCtD
Dronedarone—Vasculitis—Methotrexate—muscle cancer	0.00182	0.0133	CcSEcCtD
Dronedarone—ADRA2A—cardiac atrium—muscle cancer	0.00182	0.00394	CbGeAlD
Dronedarone—Erythema—Dactinomycin—muscle cancer	0.00179	0.0131	CcSEcCtD
Dronedarone—ADRA1A—head—muscle cancer	0.00179	0.00387	CbGeAlD
Dronedarone—KCNH2—head—muscle cancer	0.00173	0.00374	CbGeAlD
Dronedarone—Cardiac disorder—Vincristine—muscle cancer	0.00171	0.0125	CcSEcCtD
Dronedarone—ADRA2C—head—muscle cancer	0.00171	0.00369	CbGeAlD
Dronedarone—Pneumonia—Etoposide—muscle cancer	0.00167	0.0122	CcSEcCtD
Dronedarone—Angiopathy—Vincristine—muscle cancer	0.00167	0.0122	CcSEcCtD
Dronedarone—KCNH2—testis—muscle cancer	0.00167	0.00361	CbGeAlD
Dronedarone—Mediastinal disorder—Vincristine—muscle cancer	0.00166	0.0121	CcSEcCtD
Dronedarone—ADRA2C—testis—muscle cancer	0.00165	0.00356	CbGeAlD
Dronedarone—CYP3A4—renal system—muscle cancer	0.0016	0.00346	CbGeAlD
Dronedarone—ADRA2A—tendon—muscle cancer	0.00159	0.00343	CbGeAlD
Dronedarone—CYP2D6—renal system—muscle cancer	0.00158	0.00341	CbGeAlD
Dronedarone—Hepatobiliary disease—Etoposide—muscle cancer	0.00157	0.0115	CcSEcCtD
Dronedarone—ABCB1—embryo—muscle cancer	0.0015	0.00324	CbGeAlD
Dronedarone—ADRA2A—vagina—muscle cancer	0.00147	0.00318	CbGeAlD
Dronedarone—Cardiac disorder—Etoposide—muscle cancer	0.00138	0.0101	CcSEcCtD
Dronedarone—ADRA2A—head—muscle cancer	0.00136	0.00294	CbGeAlD
Dronedarone—Angiopathy—Etoposide—muscle cancer	0.00135	0.00988	CcSEcCtD
Dronedarone—Immune system disorder—Etoposide—muscle cancer	0.00135	0.00983	CcSEcCtD
Dronedarone—Mediastinal disorder—Etoposide—muscle cancer	0.00134	0.00981	CcSEcCtD
Dronedarone—ADRA2A—testis—muscle cancer	0.00132	0.00284	CbGeAlD
Dronedarone—Anaphylactic shock—Vincristine—muscle cancer	0.00131	0.00955	CcSEcCtD
Dronedarone—Nervous system disorder—Vincristine—muscle cancer	0.00128	0.00936	CcSEcCtD
Dronedarone—Dysgeusia—Etoposide—muscle cancer	0.00127	0.00928	CcSEcCtD
Dronedarone—Fatigue—Dactinomycin—muscle cancer	0.00126	0.00921	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—muscle cancer	0.00124	0.00908	CcSEcCtD
Dronedarone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00123	0.009	CcSEcCtD
Dronedarone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0012	0.00874	CcSEcCtD
Dronedarone—Abdominal pain—Dactinomycin—muscle cancer	0.00116	0.00845	CcSEcCtD
Dronedarone—Cardiac failure—Doxorubicin—muscle cancer	0.00115	0.00836	CcSEcCtD
Dronedarone—ABCB1—renal system—muscle cancer	0.00113	0.00245	CbGeAlD
Dronedarone—Gastrointestinal disorder—Vincristine—muscle cancer	0.00113	0.00824	CcSEcCtD
Dronedarone—Fatigue—Vincristine—muscle cancer	0.00113	0.00823	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0011	0.00801	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vincristine—muscle cancer	0.00107	0.00781	CcSEcCtD
Dronedarone—Anaphylactic shock—Etoposide—muscle cancer	0.00106	0.00773	CcSEcCtD
Dronedarone—CYP2D6—head—muscle cancer	0.00105	0.00228	CbGeAlD
Dronedarone—Asthenia—Dactinomycin—muscle cancer	0.00105	0.00767	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—muscle cancer	0.00105	0.00765	CcSEcCtD
Dronedarone—Abdominal pain—Vincristine—muscle cancer	0.00103	0.00755	CcSEcCtD
Dronedarone—Skin disorder—Etoposide—muscle cancer	0.00103	0.00751	CcSEcCtD
Dronedarone—Photosensitivity reaction—Methotrexate—muscle cancer	0.00102	0.00744	CcSEcCtD
Dronedarone—CYP2D6—testis—muscle cancer	0.00102	0.0022	CbGeAlD
Dronedarone—Hypokalaemia—Doxorubicin—muscle cancer	0.00102	0.00743	CcSEcCtD
Dronedarone—Diarrhoea—Dactinomycin—muscle cancer	0.001	0.00731	CcSEcCtD
Dronedarone—Pneumonia—Methotrexate—muscle cancer	0.001	0.00731	CcSEcCtD
Dronedarone—Hepatobiliary disease—Methotrexate—muscle cancer	0.000942	0.00687	CcSEcCtD
Dronedarone—Asthenia—Vincristine—muscle cancer	0.000939	0.00685	CcSEcCtD
Dronedarone—Vomiting—Dactinomycin—muscle cancer	0.000931	0.00679	CcSEcCtD
Dronedarone—Rash—Dactinomycin—muscle cancer	0.000924	0.00674	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000915	0.00668	CcSEcCtD
Dronedarone—Fatigue—Etoposide—muscle cancer	0.000914	0.00667	CcSEcCtD
Dronedarone—Diarrhoea—Vincristine—muscle cancer	0.000895	0.00653	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000883	0.00644	CcSEcCtD
Dronedarone—Nausea—Dactinomycin—muscle cancer	0.00087	0.00635	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—muscle cancer	0.000867	0.00633	CcSEcCtD
Dronedarone—Gastrointestinal pain—Etoposide—muscle cancer	0.000867	0.00632	CcSEcCtD
Dronedarone—ABCB1—bone marrow—muscle cancer	0.000857	0.00185	CbGeAlD
Dronedarone—Abdominal pain—Etoposide—muscle cancer	0.000838	0.00611	CcSEcCtD
Dronedarone—Vomiting—Vincristine—muscle cancer	0.000832	0.00607	CcSEcCtD
Dronedarone—Cardiac disorder—Methotrexate—muscle cancer	0.00083	0.00605	CcSEcCtD
Dronedarone—Rash—Vincristine—muscle cancer	0.000825	0.00602	CcSEcCtD
Dronedarone—Dermatitis—Vincristine—muscle cancer	0.000824	0.00601	CcSEcCtD
Dronedarone—ABCB1—vagina—muscle cancer	0.000821	0.00177	CbGeAlD
Dronedarone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000815	0.00595	CcSEcCtD
Dronedarone—Angiopathy—Methotrexate—muscle cancer	0.000811	0.00592	CcSEcCtD
Dronedarone—Immune system disorder—Methotrexate—muscle cancer	0.000807	0.00589	CcSEcCtD
Dronedarone—Mediastinal disorder—Methotrexate—muscle cancer	0.000806	0.00588	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—muscle cancer	0.000788	0.00575	CcSEcCtD
Dronedarone—Erythema—Methotrexate—muscle cancer	0.000778	0.00568	CcSEcCtD
Dronedarone—Nausea—Vincristine—muscle cancer	0.000777	0.00567	CcSEcCtD
Dronedarone—Dysgeusia—Methotrexate—muscle cancer	0.000762	0.00556	CcSEcCtD
Dronedarone—Asthenia—Etoposide—muscle cancer	0.000761	0.00555	CcSEcCtD
Dronedarone—ABCB1—head—muscle cancer	0.000759	0.00164	CbGeAlD
Dronedarone—Pruritus—Etoposide—muscle cancer	0.00075	0.00547	CcSEcCtD
Dronedarone—ABCB1—testis—muscle cancer	0.000733	0.00158	CbGeAlD
Dronedarone—Diarrhoea—Etoposide—muscle cancer	0.000725	0.00529	CcSEcCtD
Dronedarone—Cardiac disorder—Doxorubicin—muscle cancer	0.000718	0.00524	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—muscle cancer	0.000702	0.00512	CcSEcCtD
Dronedarone—Immune system disorder—Doxorubicin—muscle cancer	0.000699	0.0051	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000698	0.00509	CcSEcCtD
Dronedarone—Vomiting—Etoposide—muscle cancer	0.000674	0.00492	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—muscle cancer	0.000674	0.00491	CcSEcCtD
Dronedarone—Rash—Etoposide—muscle cancer	0.000668	0.00488	CcSEcCtD
Dronedarone—Dermatitis—Etoposide—muscle cancer	0.000668	0.00487	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—muscle cancer	0.00066	0.00481	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000658	0.0048	CcSEcCtD
Dronedarone—Anaphylactic shock—Methotrexate—muscle cancer	0.000635	0.00463	CcSEcCtD
Dronedarone—Nausea—Etoposide—muscle cancer	0.00063	0.00459	CcSEcCtD
Dronedarone—Nervous system disorder—Methotrexate—muscle cancer	0.000623	0.00454	CcSEcCtD
Dronedarone—Skin disorder—Methotrexate—muscle cancer	0.000617	0.0045	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00057	0.00416	CcSEcCtD
Dronedarone—CACNB3—Metabolism—FH—muscle cancer	0.000559	0.00411	CbGpPWpGaD
Dronedarone—Dyspepsia—Methotrexate—muscle cancer	0.000559	0.00408	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—muscle cancer	0.00055	0.00401	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000548	0.004	CcSEcCtD
Dronedarone—Fatigue—Methotrexate—muscle cancer	0.000547	0.00399	CcSEcCtD
Dronedarone—CACNB4—Developmental Biology—FOXO1—muscle cancer	0.000546	0.00401	CbGpPWpGaD
Dronedarone—CACNB3—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000539	0.00396	CbGpPWpGaD
Dronedarone—Nervous system disorder—Doxorubicin—muscle cancer	0.000539	0.00393	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—muscle cancer	0.000534	0.0039	CcSEcCtD
Dronedarone—CACNB2—Developmental Biology—MYOD1—muscle cancer	0.000531	0.0039	CbGpPWpGaD
Dronedarone—CACNB1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000525	0.00385	CbGpPWpGaD
Dronedarone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000519	0.00379	CcSEcCtD
Dronedarone—CACNB4—Neuronal System—MDM2—muscle cancer	0.000517	0.0038	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—MYOD1—muscle cancer	0.000503	0.00369	CbGpPWpGaD
Dronedarone—Abdominal pain—Methotrexate—muscle cancer	0.000502	0.00366	CcSEcCtD
Dronedarone—KCNK2—Neuronal System—MDM2—muscle cancer	0.000486	0.00357	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—MED12—muscle cancer	0.000485	0.00356	CbGpPWpGaD
Dronedarone—Dyspepsia—Doxorubicin—muscle cancer	0.000484	0.00353	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000475	0.00346	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—muscle cancer	0.000474	0.00346	CcSEcCtD
Dronedarone—CACNA1S—Alzheimers Disease—TP53—muscle cancer	0.000464	0.0034	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—MED12—muscle cancer	0.00046	0.00337	CbGpPWpGaD
Dronedarone—Asthenia—Methotrexate—muscle cancer	0.000456	0.00332	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00045	0.00328	CcSEcCtD
Dronedarone—Pruritus—Methotrexate—muscle cancer	0.000449	0.00328	CcSEcCtD
Dronedarone—CACNA1C—Developmental Biology—MYOD1—muscle cancer	0.000442	0.00324	CbGpPWpGaD
Dronedarone—CACNB3—Developmental Biology—FOXO1—muscle cancer	0.000436	0.0032	CbGpPWpGaD
Dronedarone—Abdominal pain—Doxorubicin—muscle cancer	0.000435	0.00317	CcSEcCtD
Dronedarone—Diarrhoea—Methotrexate—muscle cancer	0.000434	0.00317	CcSEcCtD
Dronedarone—CACNB1—Developmental Biology—FOXO1—muscle cancer	0.000424	0.00311	CbGpPWpGaD
Dronedarone—CACNB3—Neuronal System—MDM2—muscle cancer	0.000413	0.00303	CbGpPWpGaD
Dronedarone—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000407	0.00299	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—MED12—muscle cancer	0.000404	0.00297	CbGpPWpGaD
Dronedarone—Vomiting—Methotrexate—muscle cancer	0.000404	0.00295	CcSEcCtD
Dronedarone—CACNB1—Neuronal System—MDM2—muscle cancer	0.000402	0.00295	CbGpPWpGaD
Dronedarone—Rash—Methotrexate—muscle cancer	0.0004	0.00292	CcSEcCtD
Dronedarone—Dermatitis—Methotrexate—muscle cancer	0.0004	0.00292	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—muscle cancer	0.000395	0.00288	CcSEcCtD
Dronedarone—ALB—Platelet degranulation—IGF2—muscle cancer	0.000394	0.00289	CbGpPWpGaD
Dronedarone—Pruritus—Doxorubicin—muscle cancer	0.000389	0.00284	CcSEcCtD
Dronedarone—Nausea—Methotrexate—muscle cancer	0.000377	0.00275	CcSEcCtD
Dronedarone—CACNA1D—Alzheimers Disease—TP53—muscle cancer	0.000376	0.00276	CbGpPWpGaD
Dronedarone—Diarrhoea—Doxorubicin—muscle cancer	0.000376	0.00274	CcSEcCtD
Dronedarone—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000375	0.00276	CbGpPWpGaD
Dronedarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	0.000358	0.00263	CbGpPWpGaD
Dronedarone—Vomiting—Doxorubicin—muscle cancer	0.00035	0.00255	CcSEcCtD
Dronedarone—ADRA1D—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000349	0.00256	CbGpPWpGaD
Dronedarone—CACNB4—Axon guidance—VEGFA—muscle cancer	0.000348	0.00256	CbGpPWpGaD
Dronedarone—Rash—Doxorubicin—muscle cancer	0.000347	0.00253	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—muscle cancer	0.000346	0.00253	CcSEcCtD
Dronedarone—CACNB2—Metabolism—FH—muscle cancer	0.000342	0.00251	CbGpPWpGaD
Dronedarone—ADRA2B—G alpha (i) signalling events—CNR1—muscle cancer	0.00034	0.0025	CbGpPWpGaD
Dronedarone—CACNA1C—Alzheimers Disease—TP53—muscle cancer	0.000331	0.00243	CbGpPWpGaD
Dronedarone—CACNB2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.00033	0.00242	CbGpPWpGaD
Dronedarone—Nausea—Doxorubicin—muscle cancer	0.000327	0.00238	CcSEcCtD
Dronedarone—CACNA1D—Metabolism—FH—muscle cancer	0.000324	0.00238	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—FOXO1—muscle cancer	0.000319	0.00234	CbGpPWpGaD
Dronedarone—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000318	0.00234	CbGpPWpGaD
Dronedarone—ADRA2C—G alpha (i) signalling events—CNR1—muscle cancer	0.000317	0.00233	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—MED12—muscle cancer	0.000316	0.00232	CbGpPWpGaD
Dronedarone—ADRA2B—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000315	0.00232	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—FOXO1—muscle cancer	0.000311	0.00228	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—ANGPT2—muscle cancer	0.000309	0.00227	CbGpPWpGaD
Dronedarone—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000299	0.0022	CbGpPWpGaD
Dronedarone—ADRA2C—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000295	0.00216	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000293	0.00215	CbGpPWpGaD
Dronedarone—ADRA2B—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000292	0.00214	CbGpPWpGaD
Dronedarone—ADRA1B—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.00029	0.00213	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—ANGPT2—muscle cancer	0.000289	0.00212	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—ENO2—muscle cancer	0.000288	0.00212	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—FH—muscle cancer	0.000284	0.00209	CbGpPWpGaD
Dronedarone—CACNB3—Axon guidance—VEGFA—muscle cancer	0.000278	0.00204	CbGpPWpGaD
Dronedarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000273	0.002	CbGpPWpGaD
Dronedarone—ADRA2C—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000273	0.002	CbGpPWpGaD
Dronedarone—CACNB1—Axon guidance—VEGFA—muscle cancer	0.000271	0.00199	CbGpPWpGaD
Dronedarone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.00027	0.00198	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR ligand binding—PTCH1—muscle cancer	0.00027	0.00198	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—FOXO1—muscle cancer	0.000266	0.00196	CbGpPWpGaD
Dronedarone—ADRA2A—G alpha (i) signalling events—CNR1—muscle cancer	0.000258	0.00189	CbGpPWpGaD
Dronedarone—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000258	0.00189	CbGpPWpGaD
Dronedarone—CACNB2—Neuronal System—MDM2—muscle cancer	0.000252	0.00185	CbGpPWpGaD
Dronedarone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000252	0.00185	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—FOXO1—muscle cancer	0.000252	0.00185	CbGpPWpGaD
Dronedarone—KCNH2—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000249	0.00183	CbGpPWpGaD
Dronedarone—CACNB4—Developmental Biology—VEGFA—muscle cancer	0.000249	0.00183	CbGpPWpGaD
Dronedarone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000248	0.00182	CbGpPWpGaD
Dronedarone—ADRB1—GPCR ligand binding—PTCH1—muscle cancer	0.000246	0.00181	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR ligand binding—PTCH1—muscle cancer	0.000244	0.00179	CbGpPWpGaD
Dronedarone—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000239	0.00176	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—ANGPT2—muscle cancer	0.000235	0.00172	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR ligand binding—CNR1—muscle cancer	0.000228	0.00167	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR ligand binding—PTCH1—muscle cancer	0.000228	0.00167	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR ligand binding—PTCH1—muscle cancer	0.000224	0.00165	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—FOXO1—muscle cancer	0.000222	0.00163	CbGpPWpGaD
Dronedarone—ADRA2A—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000221	0.00163	CbGpPWpGaD
Dronedarone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000221	0.00162	CbGpPWpGaD
Dronedarone—ADRA1B—AMPK Signaling—TP53—muscle cancer	0.000216	0.00158	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000214	0.00157	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KIDINS220—muscle cancer	0.000208	0.00153	CbGpPWpGaD
Dronedarone—ADRB1—GPCR ligand binding—CNR1—muscle cancer	0.000208	0.00152	CbGpPWpGaD
Dronedarone—KCNH2—Neuronal System—MDM2—muscle cancer	0.000206	0.00151	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR ligand binding—CNR1—muscle cancer	0.000206	0.00151	CbGpPWpGaD
Dronedarone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000205	0.00151	CbGpPWpGaD
Dronedarone—SCN1A—Axon guidance—VEGFA—muscle cancer	0.000204	0.00149	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—PTCH1—muscle cancer	0.000199	0.00146	CbGpPWpGaD
Dronedarone—CACNB3—Developmental Biology—VEGFA—muscle cancer	0.000199	0.00146	CbGpPWpGaD
Dronedarone—CACNA1S—Axon guidance—VEGFA—muscle cancer	0.000198	0.00146	CbGpPWpGaD
Dronedarone—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000194	0.00143	CbGpPWpGaD
Dronedarone—CACNB1—Developmental Biology—VEGFA—muscle cancer	0.000193	0.00142	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—MED12—muscle cancer	0.000193	0.00142	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR ligand binding—CNR1—muscle cancer	0.000192	0.00141	CbGpPWpGaD
Dronedarone—ADRA1A—AMPK Signaling—TP53—muscle cancer	0.000192	0.00141	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KIDINS220—muscle cancer	0.000189	0.00139	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR ligand binding—CNR1—muscle cancer	0.000189	0.00139	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KIDINS220—muscle cancer	0.000188	0.00138	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—ANGPT2—muscle cancer	0.000185	0.00136	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—PTCH1—muscle cancer	0.000185	0.00136	CbGpPWpGaD
Dronedarone—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	0.000183	0.00134	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—MED12—muscle cancer	0.000183	0.00134	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—ENO2—muscle cancer	0.000176	0.00129	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KIDINS220—muscle cancer	0.000175	0.00129	CbGpPWpGaD
Dronedarone—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000175	0.00128	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KIDINS220—muscle cancer	0.000173	0.00127	CbGpPWpGaD
Dronedarone—CACNB2—Axon guidance—VEGFA—muscle cancer	0.00017	0.00125	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—FH—muscle cancer	0.000169	0.00124	CbGpPWpGaD
Dronedarone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	0.000169	0.00124	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—CNR1—muscle cancer	0.000168	0.00123	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—ENO2—muscle cancer	0.000167	0.00122	CbGpPWpGaD
Dronedarone—ALB—Platelet degranulation—VEGFA—muscle cancer	0.000165	0.00121	CbGpPWpGaD
Dronedarone—CACNA1D—Axon guidance—VEGFA—muscle cancer	0.000161	0.00118	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—MED12—muscle cancer	0.000161	0.00118	CbGpPWpGaD
Dronedarone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.000157	0.00116	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—CNR1—muscle cancer	0.000156	0.00115	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KIDINS220—muscle cancer	0.000153	0.00113	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—IGF2—muscle cancer	0.00015	0.0011	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—ENO2—muscle cancer	0.000146	0.00108	CbGpPWpGaD
Dronedarone—ABCB1—Allograft Rejection—VEGFA—muscle cancer	0.000146	0.00107	CbGpPWpGaD
Dronedarone—ALB—Folate Metabolism—TP53—muscle cancer	0.000146	0.00107	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—VEGFA—muscle cancer	0.000145	0.00107	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KIDINS220—muscle cancer	0.000142	0.00105	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—VEGFA—muscle cancer	0.000142	0.00104	CbGpPWpGaD
Dronedarone—CACNA1C—Axon guidance—VEGFA—muscle cancer	0.000142	0.00104	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—IGF2—muscle cancer	0.000141	0.00103	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—PTCH1—muscle cancer	0.000139	0.00102	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000137	0.00101	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—FH—muscle cancer	0.000137	0.00101	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CNR1—muscle cancer	0.000129	0.000946	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—PTCH1—muscle cancer	0.000126	0.000927	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—PTCH1—muscle cancer	0.000125	0.000919	CbGpPWpGaD
Dronedarone—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000122	0.000899	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—VEGFA—muscle cancer	0.000121	0.000891	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CNR1—muscle cancer	0.000117	0.000862	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CNR1—muscle cancer	0.000117	0.000859	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—PTCH1—muscle cancer	0.000117	0.000858	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000116	0.000854	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—PTCH1—muscle cancer	0.000115	0.000844	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—VEGFA—muscle cancer	0.000115	0.000844	CbGpPWpGaD
Dronedarone—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000114	0.000839	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—IGF2—muscle cancer	0.000114	0.000838	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CNR1—muscle cancer	0.000109	0.000798	CbGpPWpGaD
Dronedarone—ALB—Metabolism—FH—muscle cancer	0.000108	0.000796	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CNR1—muscle cancer	0.000107	0.000785	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CNR1—muscle cancer	0.000107	0.000782	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CNR1—muscle cancer	0.000106	0.000775	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PTCH1—muscle cancer	0.000102	0.00075	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—VEGFA—muscle cancer	0.000101	0.000742	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—PTGS2—muscle cancer	0.0001	0.000737	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CNR1—muscle cancer	9.86e-05	0.000724	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CNR1—muscle cancer	9.71e-05	0.000713	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—MED12—muscle cancer	9.55e-05	0.000701	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	9.5e-05	0.000698	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CNR1—muscle cancer	9.5e-05	0.000697	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—FH—muscle cancer	9.5e-05	0.000697	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PTCH1—muscle cancer	9.49e-05	0.000697	CbGpPWpGaD
Dronedarone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	9.29e-05	0.000682	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	9.16e-05	0.000673	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—IGF2—muscle cancer	9.01e-05	0.000661	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—FH—muscle cancer	8.95e-05	0.000657	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CNR1—muscle cancer	8.82e-05	0.000648	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ENO2—muscle cancer	8.71e-05	0.000639	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CNR1—muscle cancer	8.62e-05	0.000633	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTCH1—muscle cancer	8.19e-05	0.000601	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	8.01e-05	0.000588	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—MED12—muscle cancer	7.76e-05	0.00057	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTCH1—muscle cancer	7.46e-05	0.000548	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTCH1—muscle cancer	7.39e-05	0.000543	CbGpPWpGaD
Dronedarone—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	7.33e-05	0.000538	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.22e-05	0.00053	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ENO2—muscle cancer	7.07e-05	0.000519	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—FOXO4—muscle cancer	7.04e-05	0.000517	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CNR1—muscle cancer	6.91e-05	0.000507	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTCH1—muscle cancer	6.9e-05	0.000507	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	6.79e-05	0.000499	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—FOXO4—muscle cancer	6.41e-05	0.000471	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—FOXO4—muscle cancer	6.36e-05	0.000467	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—VEGFA—muscle cancer	6.31e-05	0.000463	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CNR1—muscle cancer	6.3e-05	0.000462	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CNR1—muscle cancer	6.24e-05	0.000458	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—PTGS2—muscle cancer	6.13e-05	0.00045	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MED12—muscle cancer	6.12e-05	0.00045	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	6.03e-05	0.000443	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—FOXO4—muscle cancer	5.94e-05	0.000436	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—VEGFA—muscle cancer	5.89e-05	0.000433	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—FH—muscle cancer	5.85e-05	0.00043	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	5.84e-05	0.000429	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CNR1—muscle cancer	5.83e-05	0.000428	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—PTGS2—muscle cancer	5.8e-05	0.000426	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CNR1—muscle cancer	5.73e-05	0.000421	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IGF2—muscle cancer	5.65e-05	0.000415	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	5.61e-05	0.000412	CbGpPWpGaD
Dronedarone—ALB—Metabolism—ENO2—muscle cancer	5.58e-05	0.00041	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.45e-05	0.0004	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MED12—muscle cancer	5.37e-05	0.000394	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—FOXO1—muscle cancer	5.2e-05	0.000382	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	5.19e-05	0.000381	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IGF2—muscle cancer	5.15e-05	0.000378	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—PTGS2—muscle cancer	5.1e-05	0.000374	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IGF2—muscle cancer	5.1e-05	0.000374	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CNR1—muscle cancer	5.09e-05	0.000374	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MED12—muscle cancer	5.06e-05	0.000371	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ENO2—muscle cancer	4.89e-05	0.000359	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	4.82e-05	0.000354	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—VEGFA—muscle cancer	4.79e-05	0.000351	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—TP53—muscle cancer	4.77e-05	0.00035	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF2—muscle cancer	4.76e-05	0.00035	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—FOXO1—muscle cancer	4.74e-05	0.000348	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CNR1—muscle cancer	4.73e-05	0.000347	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—FOXO1—muscle cancer	4.69e-05	0.000345	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF2—muscle cancer	4.69e-05	0.000344	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ENO2—muscle cancer	4.61e-05	0.000338	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—TP53—muscle cancer	4.45e-05	0.000327	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—FOXO1—muscle cancer	4.38e-05	0.000322	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.37e-05	0.000321	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	4.31e-05	0.000317	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF2—muscle cancer	4.16e-05	0.000306	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KIT—muscle cancer	3.96e-05	0.000291	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF2—muscle cancer	3.87e-05	0.000284	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	3.83e-05	0.000281	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—VEGFA—muscle cancer	3.78e-05	0.000277	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TP53—muscle cancer	3.62e-05	0.000266	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KIT—muscle cancer	3.61e-05	0.000265	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KIT—muscle cancer	3.58e-05	0.000263	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	3.56e-05	0.000261	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KIT—muscle cancer	3.34e-05	0.000245	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MED12—muscle cancer	3.31e-05	0.000243	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KIT—muscle cancer	3.29e-05	0.000241	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MDM2—muscle cancer	3.12e-05	0.000229	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—muscle cancer	3.03e-05	0.000223	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ENO2—muscle cancer	3.01e-05	0.000221	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KIT—muscle cancer	2.92e-05	0.000214	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—muscle cancer	2.85e-05	0.00021	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MDM2—muscle cancer	2.84e-05	0.000209	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MDM2—muscle cancer	2.82e-05	0.000207	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KIT—muscle cancer	2.71e-05	0.000199	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MDM2—muscle cancer	2.63e-05	0.000193	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MDM2—muscle cancer	2.59e-05	0.00019	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—muscle cancer	2.46e-05	0.000181	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—muscle cancer	2.37e-05	0.000174	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MDM2—muscle cancer	2.3e-05	0.000169	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—muscle cancer	2.16e-05	0.000158	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—muscle cancer	2.14e-05	0.000157	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MDM2—muscle cancer	2.14e-05	0.000157	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—muscle cancer	2e-05	0.000147	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	1.97e-05	0.000144	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—muscle cancer	1.94e-05	0.000143	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—muscle cancer	1.79e-05	0.000131	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	1.75e-05	0.000128	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—muscle cancer	1.7e-05	0.000125	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—muscle cancer	1.63e-05	0.00012	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	1.62e-05	0.000119	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—muscle cancer	1.62e-05	0.000119	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—muscle cancer	1.61e-05	0.000118	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—muscle cancer	1.51e-05	0.000111	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—muscle cancer	1.49e-05	0.000109	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—muscle cancer	1.32e-05	9.69e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—muscle cancer	1.23e-05	9e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—muscle cancer	1.05e-05	7.71e-05	CbGpPWpGaD
